Martín C. Mihm

Top papers

• Final Version of 2009 AJCC Melanoma Staging and Classification

  Charles M. Balch, Jeffrey E. Gershenwald, Seng-Jaw Soong, et al.·2009·Journal of Clinical Oncology
  ↗ 4,558OA
• The histogenesis and biologic behavior of primary human malignant melanomas of the skin.

  Wallace H. Clark, Lynn From, Evelina A. Bernardino, et al.·1969·PubMed
  ↗ 2,135
• Melanoma

  Arlo J. Miller, Martín C. Mihm·2006·New England Journal of Medicine
  ↗ 1,313
• Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma

  Claudio G. Clemente, Martín C. Mihm, Rosaria Bufalino, et al.·1996·Cancer
  ↗ 1,125OA
• Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients

  F. Stephen Hodi, Martín C. Mihm, Robert J. Soiffer, et al.·2003·Proceedings of the National Academy of Sciences
  ↗ 997OA
• GLUT1: A newly discovered immunohistochemical marker for juvenile hemangiomas

  Paula E. North, Milton Waner, Adam Mizeracki, et al.·2000·Human Pathology
  ↗ 844
• Loss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of Melanoma

  Christine G. Lian, Yufei Xu, Craig J. Ceol, et al.·2012·Cell
  ↗ 801OA
• Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients

  F. Stephen Hodi, Marcus O. Butler, Darryl A. Oble, et al.·2008·Proceedings of the National Academy of Sciences
  ↗ 648OA
• Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth

  Sonja Kleffel, Christian Posch, Steven R. Barthel, et al.·2015·Cell
  ↗ 644OA
• Efficacy of an Elective Regional Lymph Node Dissection of 1 to 4 mm Thick Melanomas for Patients 60 Years of Age and Younger

  Charles M. Balch, Seng-Jaw Soong, Alfred A. Bartolucci, et al.·1996·Annals of Surgery
  ↗ 634OA
• Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma

  F. Stephen Hodi, Donald P. Lawrence, Cecilia Lezcano, et al.·2014·Cancer Immunology Research
  ↗ 602OA
• Efficacy of 2-cm Surgical Margins for Intermediate-Thickness Melanomas (1 to 4 mm) Results of a Multi-institutional Randomized Surgical Trial

  Charles M. Balch, Marshall M. Urist, Constantine P. Karakousis, et al.·1993·Annals of Surgery
  ↗ 526OA